Zai Lab Limited ADR (NASDAQ:ZLAB)’s traded shares stood at 1.06 million during the latest session, with the company’s beta value hitting 1.16. At the last check today, the stock’s price was $28.82, to imply an increase of 18.48% or $4.5 in intraday trading. The ZLAB share’s 52-week high remains $39.77, putting it -37.99% down since that peak but still an impressive 53.23% since price per share fell to its 52-week low of $13.48. The company has a valuation of $3.16B, with an average of 2.0 million shares in intraday trading volume over the past 10 days and average of 1.08 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Zai Lab Limited ADR (ZLAB), translating to a mean rating of 1.29. Of 2 analyst(s) looking at the stock, 0 analyst(s) give ZLAB a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy.
Zai Lab Limited ADR (NASDAQ:ZLAB) trade information
After registering a 18.48% upside in the latest session, Zai Lab Limited ADR (ZLAB) has traded red over the past five days. The 5-day price performance for the stock is -9.30%, and -20.27% over 30 days. With these gigs, the year-to-date price performance is 10.02%. Short interest in Zai Lab Limited ADR (NASDAQ:ZLAB) saw shorts transact 7.92 million shares and set a 5.97 days time to cover.
The extremes give us $55 and $55 for target low and target high price respectively. As such, ZLAB has been trading -90.84% off suggested target high and -90.84% from its likely low.
ZLAB Dividends
Zai Lab Limited ADR has its next earnings report out on 2025-Feb-26. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Zai Lab Limited ADR (NASDAQ:ZLAB)’s Major holders
Zai Lab Limited ADR insiders hold 1.44% of total outstanding shares, with institutional holders owning 54.38% of the shares at 55.17% float percentage. In total, 54.38% institutions holds shares in the company, led by PRICE T ROWE ASSOCIATES INC /MD/. As of 2024-06-30, the company held over 1.66 million shares (or 1.7037% of shares), all amounting to roughly $28.73 million.
The next major institution holding the largest number of shares is WELLINGTON MANAGEMENT GROUP LLP with 7.12 million shares, or about 0.73% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $123.47 million.
We also have New World Fund Inc and VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund as the top two Mutual Funds with the largest holdings of the Zai Lab Limited ADR (ZLAB) shares. Going by data provided on Jan 31, 2025 , New World Fund Inc holds roughly 3.28 shares. This is just over 2.99% of the total shares, with a market valuation of $93.41 million. Data from the same date shows that the other fund manager holds a little less at 2.9, or 2.64% of the shares, all valued at about 82.48 million.
